Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
Drugs|April 20, 2006
Advances in the treatment of testicular cancerHans-Georg Kopp, Markus Kuczyk, Johannes Classen, et al.
Oncotarget|February 13, 2016
Enhanced eryptosis contributes to anemia in lung cancer patientsRosi Bissinger, Carla Schumacher, Syed M Qadri, et al.
Frontiers in Cellular Neuroscience|September 26, 2019
Poly (ADP-Ribose) Polymerase-1 (PARP1) Deficiency and Pharmacological Inhibition by Pirenzepine Protects From Cisplatin-Induced Ototoxicity Without Affecting Antitumor EfficacyAnke Tropitzsch, Marcus Müller, François Paquet-Durand, et al.
Molecular and Clinical Oncology|October 2, 2020
Hepatic toxicity during regorafenib treatment in patients with metastatic gastrointestinal stromal tumorsPhilipp Ivanyi, Hendrik Eggers, Mareike Hornig, et al.
Frontiers in Oncology|May 21, 2024
Activity of afatinib in patients with NSCLC harboring novel uncommon <i>EGFR</i> mutations with or without co-mutations: a case reportPetros Christopoulos, Franziska Herster, Petra Hoffknecht, et al.
Blood|April 9, 2005
Tie2 activation contributes to hemangiogenic regeneration after myelosuppressionHans-Georg Kopp, Scott T Avecilla, Andrea T Hooper, et al.
European Journal of Haematology|January 24, 2018
Low plasma protein Z levels are associated with an increased risk for perioperative bleedingsClemens Hinterleitner, Klaus-Peter Kreisselmeier, Ann-Christin Pecher, et al.
BMC Cancer|December 18, 2015
Choroidal metastases from thymic carcinoma during pregnancy: Case ReportSebastian P Haen, Philipp Stroebel, Alexander Marx, et al.
BMC Research Notes|June 3, 2014
Paraneoplastic granulocyte colony-stimulating factor secretion in soft tissue sarcoma mimicking myeloproliferative neoplasia: a case reportChristiane Dorn, Stefanie Bugl, Elke Malenke, et al.
Journal of Cancer Research and Clinical Oncology|September 21, 2018
Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study GroupMartin Fenner, Christoph Oing, Annette Dieing, et al.
Pageof 10